Selected research
Industry Research
Next Generation Sequencing (NGS) Service Industry Research Report 2026
Market perspective
The global Next Generation Sequencing (NGS) Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Next Generation Sequencing (NGS) Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Next Generation Sequencing (NGS) Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Next Generation Sequencing (NGS) Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Next Generation Sequencing (NGS) Service include CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology Corporation, EMC Corporation, Dnastar and 454 Life Sciences Corporation (Roche), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Next Generation Sequencing (NGS) Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Next Generation Sequencing (NGS) Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Next Generation Sequencing (NGS) Service Market by Company
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
454 Life Sciences Corporation (Roche)
Agilent Technologies
Biomatters, Ltd
Next Generation Sequencing (NGS) Service Segment by Type
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Next Generation Sequencing (NGS) Service Segment by Application
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
Next Generation Sequencing (NGS) Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next Generation Sequencing (NGS) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Next Generation Sequencing (NGS) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next Generation Sequencing (NGS) Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Next Generation Sequencing (NGS) Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Targeted Sequencing & Resequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
Applications
- Whole-genome Sequencing
- Exome Sequencing
- Targeted Resequencing
- De Novo Sequencing
- RNA Sequencing
- ChIP Sequencing
- Methyl Sequencing
- Others
Companies covered
- CLC Bio
- GATC biotech AG
- Macrogen
- BGI (Beijing Genomics Institute)
- Illumina
- Life Technology Corporation
- EMC Corporation
- Dnastar
- 454 Life Sciences Corporation (Roche)
- Agilent Technologies
- Biomatters, Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Next Generation Sequencing (NGS) Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Targeted Sequencing & Resequencing
- 2.2.3 Whole Genome Sequencing
- 2.2.4 Whole Exome Sequencing
- 2.3 Next Generation Sequencing (NGS) Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Whole-genome Sequencing
- 2.3.3 Exome Sequencing
- 2.3.4 Targeted Resequencing
- 2.3.5 De Novo Sequencing
- 2.3.6 RNA Sequencing
- 2.3.7 ChIP Sequencing
- 2.3.8 Methyl Sequencing
- 2.3.9 Others
- 2.4 Assumptions and Limitations
3 Next Generation Sequencing (NGS) Service Breakdown Data by Type
- 3.1 Global Next Generation Sequencing (NGS) Service Historic Market Size by Type (2021-2026)
- 3.2 Global Next Generation Sequencing (NGS) Service Forecasted Market Size by Type (2027-2032)
4 Next Generation Sequencing (NGS) Service Breakdown Data by Application
- 4.1 Global Next Generation Sequencing (NGS) Service Historic Market Size by Application (2021-2026)
- 4.2 Global Next Generation Sequencing (NGS) Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Next Generation Sequencing (NGS) Service Market Perspective (2021-2032)
- 5.2 Global Next Generation Sequencing (NGS) Service Growth Trends by Region
- 5.2.1 Global Next Generation Sequencing (NGS) Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Next Generation Sequencing (NGS) Service Historic Market Size by Region (2021-2026)
- 5.2.3 Next Generation Sequencing (NGS) Service Forecasted Market Size by Region (2027-2032)
- 5.3 Next Generation Sequencing (NGS) Service Market Dynamics
- 5.3.1 Next Generation Sequencing (NGS) Service Industry Trends
- 5.3.2 Next Generation Sequencing (NGS) Service Market Drivers
- 5.3.3 Next Generation Sequencing (NGS) Service Market Challenges
- 5.3.4 Next Generation Sequencing (NGS) Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Next Generation Sequencing (NGS) Service Players by Revenue
- 6.1.1 Global Top Next Generation Sequencing (NGS) Service Players by Revenue (2021-2026)
- 6.1.2 Global Next Generation Sequencing (NGS) Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Next Generation Sequencing (NGS) Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Next Generation Sequencing (NGS) Service Head Office and Area Served
- 6.4 Global Next Generation Sequencing (NGS) Service Players, Product Type & Application
- 6.5 Global Next Generation Sequencing (NGS) Service Manufacturers Established Date
- 6.6 Global Next Generation Sequencing (NGS) Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Next Generation Sequencing (NGS) Service Market Size (2021-2032)
- 7.2 North America Next Generation Sequencing (NGS) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Next Generation Sequencing (NGS) Service Market Size by Country (2021-2026)
- 7.4 North America Next Generation Sequencing (NGS) Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Next Generation Sequencing (NGS) Service Market Size (2021-2032)
- 8.2 Europe Next Generation Sequencing (NGS) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Next Generation Sequencing (NGS) Service Market Size by Country (2021-2026)
- 8.4 Europe Next Generation Sequencing (NGS) Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Next Generation Sequencing (NGS) Service Market Size (2021-2032)
- 9.2 Asia-Pacific Next Generation Sequencing (NGS) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Next Generation Sequencing (NGS) Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Next Generation Sequencing (NGS) Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Next Generation Sequencing (NGS) Service Market Size (2021-2032)
- 10.2 South America Next Generation Sequencing (NGS) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Next Generation Sequencing (NGS) Service Market Size by Country (2021-2026)
- 10.4 South America Next Generation Sequencing (NGS) Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Next Generation Sequencing (NGS) Service Market Size (2021-2032)
- 11.2 Middle East & Africa Next Generation Sequencing (NGS) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Next Generation Sequencing (NGS) Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Next Generation Sequencing (NGS) Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 CLC Bio
- 12.1.1 CLC Bio Company Information
- 12.1.2 CLC Bio Business Overview
- 12.1.3 CLC Bio Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.1.4 CLC Bio Next Generation Sequencing (NGS) Service Product Portfolio
- 12.1.5 CLC Bio Recent Developments
- 12.2 GATC biotech AG
- 12.2.1 GATC biotech AG Company Information
- 12.2.2 GATC biotech AG Business Overview
- 12.2.3 GATC biotech AG Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.2.4 GATC biotech AG Next Generation Sequencing (NGS) Service Product Portfolio
- 12.2.5 GATC biotech AG Recent Developments
- 12.3 Macrogen
- 12.3.1 Macrogen Company Information
- 12.3.2 Macrogen Business Overview
- 12.3.3 Macrogen Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.3.4 Macrogen Next Generation Sequencing (NGS) Service Product Portfolio
- 12.3.5 Macrogen Recent Developments
- 12.4 BGI (Beijing Genomics Institute)
- 12.4.1 BGI (Beijing Genomics Institute) Company Information
- 12.4.2 BGI (Beijing Genomics Institute) Business Overview
- 12.4.3 BGI (Beijing Genomics Institute) Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.4.4 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Product Portfolio
- 12.4.5 BGI (Beijing Genomics Institute) Recent Developments
- 12.5 Illumina
- 12.5.1 Illumina Company Information
- 12.5.2 Illumina Business Overview
- 12.5.3 Illumina Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.5.4 Illumina Next Generation Sequencing (NGS) Service Product Portfolio
- 12.5.5 Illumina Recent Developments
- 12.6 Life Technology Corporation
- 12.6.1 Life Technology Corporation Company Information
- 12.6.2 Life Technology Corporation Business Overview
- 12.6.3 Life Technology Corporation Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.6.4 Life Technology Corporation Next Generation Sequencing (NGS) Service Product Portfolio
- 12.6.5 Life Technology Corporation Recent Developments
- 12.7 EMC Corporation
- 12.7.1 EMC Corporation Company Information
- 12.7.2 EMC Corporation Business Overview
- 12.7.3 EMC Corporation Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.7.4 EMC Corporation Next Generation Sequencing (NGS) Service Product Portfolio
- 12.7.5 EMC Corporation Recent Developments
- 12.8 Dnastar
- 12.8.1 Dnastar Company Information
- 12.8.2 Dnastar Business Overview
- 12.8.3 Dnastar Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.8.4 Dnastar Next Generation Sequencing (NGS) Service Product Portfolio
- 12.8.5 Dnastar Recent Developments
- 12.9 454 Life Sciences Corporation (Roche)
- 12.9.1 454 Life Sciences Corporation (Roche) Company Information
- 12.9.2 454 Life Sciences Corporation (Roche) Business Overview
- 12.9.3 454 Life Sciences Corporation (Roche) Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.9.4 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Product Portfolio
- 12.9.5 454 Life Sciences Corporation (Roche) Recent Developments
- 12.10 Agilent Technologies
- 12.10.1 Agilent Technologies Company Information
- 12.10.2 Agilent Technologies Business Overview
- 12.10.3 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.10.4 Agilent Technologies Next Generation Sequencing (NGS) Service Product Portfolio
- 12.10.5 Agilent Technologies Recent Developments
- 12.11 Biomatters, Ltd
- 12.11.1 Biomatters, Ltd Company Information
- 12.11.2 Biomatters, Ltd Business Overview
- 12.11.3 Biomatters, Ltd Revenue in Next Generation Sequencing (NGS) Service Business (2021-2026)
- 12.11.4 Biomatters, Ltd Next Generation Sequencing (NGS) Service Product Portfolio
- 12.11.5 Biomatters, Ltd Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst